Respiratory - European Medical Journal

Continue

Respiratory

Filter
28 Sep 2020

Can Inflammatory Biomarkers Be Used to Predict Severe COVID-19 Disease?

Researchers have identified key markers that could help predict which patients are at increased risk of developing severe COVID-19…
28 Sep 2020

Prone Position Puts Severe COVID-19 Patients on Ventilation at Risk of Permanent Nerve Damage

But according to a new study, patients seriously ill with COVID-19 could be at risk of developing permanent nerve damage from being placed in the prone…
Are Undersized Airways the Cause of COPD in Nonsmokers?
19 Jun 2020

Are Undersized Airways the Cause of COPD in Nonsmokers?

ONE IN FOUR patients with chronic obstructive pulmonary disease (COPD) have never smoked and the reasons behind this have long evaded researchers
Immunity to Respiratory Viruses by Targeting Killer T Cells
19 Jun 2020

Immunity to Respiratory Viruses by Targeting Killer T Cells

COVID-19 has been shown to significantly affect the lungs. To understand how the immune cells of the lung respond to viral infection, researchers…
Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation
5 May 2020

Artificial Intelligence May Provide Objective Means of Chest Scan Evaluation

ARTIFICIAL intelligence could be used as a crucial tool for clear, objective assessment of lung disease to aid radiologists in what has been a measured…
28 Apr 2020

Keeping Frankenstein’s Monster at Bay

I am not a fatalist, I do not believe things happen for a reason, but I do believe we can find reason in the things that happen…
6 Apr 2020

Ability to Stabilise and Stockpile Covid-19 Vaccine is Vital

An incredible global effort is underway by companies and scientists digging deep to find a vaccine for Covid-19…
Could Ivermectin be an Effective COVID-19 Treatment?
6 Apr 2020

Could Ivermectin be an Effective COVID-19 Treatment?

IVERMECTIN, an antiparasitic drug that is in use around the world, has shown to kill the SARS-CoV-2 virus within 48 hours…
We’ve noticed you’re accessing
from North/South America.